Skip to main content
Livermore
Livermore
ZHEN

Advisor Group Holdings, Inc.

SEC CIK
0001677044
Latest filing
Aug 14, 2026

AKRO holding history

Akero Therapeutics, Inc. in every 13F filed by Advisor Group Holdings, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AKRO overviewAll 13F holders of AKROFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of AKRO by Advisor Group Holdings, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−5,460−100.0%Sold outHolders
Q3 20255,460$255.4K<0.1%−840−13.3%ReducedHolders
Q2 20256,300$335.9K<0.1%−160−2.5%ReducedHolders
Q1 20256,460$261.4K<0.1%+5,352+483.0%AddedHolders
Q4 20241,108$30.8K<0.1%+8+0.7%AddedHolders
Q3 20241,100$31.6K<0.1%00.0%UnchangedHolders
Q2 20241,100$25.8K<0.1%−1,878−63.1%ReducedHolders
Q1 20242,978$75.2K<0.1%−421−12.4%ReducedHolders
Q4 20233,399$79.4K<0.1%−1,843−35.2%ReducedHolders
Q3 20235,242$265.1K<0.1%+3,433+189.8%AddedHolders
Q2 20231,809$84.5K<0.1%+359+24.8%AddedHolders
Q1 20231,450$55.5K<0.1%+315+27.8%AddedHolders
Q4 20221,135$62.0K<0.1%−289−20.3%ReducedHolders
Q3 20221,424$48.0K<0.1%+1,150+419.7%AddedHolders
Q2 2022274$3.00K<0.1%00.0%UnchangedHolders
Q1 2022274$4.00K<0.1%−723−72.5%ReducedHolders
Q4 2021997$22.0K<0.1%+112+12.7%AddedHolders
Q3 2021885$19.0K<0.1%00.0%UnchangedHolders
Q2 2021885$22.0K<0.1%−400−31.1%ReducedHolders
Q1 20211,285$37.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.